RxDoctor Payments Data

Eileen Connors

Nurse Practitioner · Jim Thorpe, PANPI 1134240005

Payments from drug & device makers

$2,082in general payments, 2019–2025

Across 121 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$597
  • AstraZeneca$335
  • Boehringer Ingelheim$274
  • AbbVie$205
  • Lilly USA, LLC$203
  • Merck$126
  • plus $343 from 11 others

What the payments were for

  • Food & beverage$2,082100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,082 in reported general payments places this provider in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.

See all nurse practitioner providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$75,724
Medicare patients
325
Services billed
3,068

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban29$21,118
OzempicSemaglutide13$18,023
Spiriva RespimatTiotropium Bromide11$5,451
Potassium Chloride18$1,605
Albuterol Sulfate HfaAlbuterol Sulfate53$1,202
Valsartan14$769
Buspirone Hcl17$655
Rosuvastatin Calcium21$459
Atorvastatin Calcium47$453
Lisinopril53$435
Celecoxib12$424
Alprazolam55$423
Levothyroxine Sodium51$411
Escitalopram Oxalate28$399
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip18$369

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$89$21,11829 claims
Novo NordiskOzempic$597$18,02313 claims
Boehringer IngelheimSpiriva Respimat$274$5,45111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,059 nurse practitioner providers in Pennsylvania.

Other nurse practitioner in Jim Thorpe

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →